Interferon-ß-1b: Prophylactic therapy in multiple sclerosis

Kenneth P. Johnson, Peter A. Calabresi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

I. INTRODUCTION Multiple sclerosis (MS) has intrigued, baffled, and challenged neurologists since it was first described by Charcot. Its typically episodic, relapsing, remitting, but eventually progressive clinical course initially suggested an infectious (in particular, viral) etiology. However, a specific virus has never been convincingly related to MS, despite a diligent and ongoing search for a causative agent. Although the etiology of MS is still not conclusively established, the preponderance of evidence suggests that it is an immune-mediated disease characterized by localization of several types of inflammatory cell types in MS lesions with altered levels of inflammatory cytokines in the serum, cerebrospinal fluid, and central nervous system (CNS) (1,2).

Original languageEnglish (US)
Title of host publicationHandbook of Multiple Sclerosis, Third Edition
PublisherCRC Press
Pages503-518
Number of pages16
ISBN (Electronic)9780824741846
ISBN (Print)9780824704858
StatePublished - Jan 1 2001
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Interferon-ß-1b: Prophylactic therapy in multiple sclerosis'. Together they form a unique fingerprint.

Cite this